Figures below are as of 21 Jul 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹-9 |
| Estimated listing gain | -6.5% |
| Estimated listing price | ₹130 |
| Issue price | ₹139 |
| Issue size | ₹52.43 Cr |
| Subscription | 2.26x |
| Open date | 21 May 2026 |
| Close date | 25 May 2026 |
| Listing date | 29 May 2026 |
| Listing at | NSE SME |
| IPO type | SME |
| Registrar | Skyline Financial Services Pvt.Ltd. |
As of 21 Jul 2026, the grey market premium (GMP) for the Bio Medica Laboratories Ltd. IPO is ₹-9, implying an estimated listing gain of about -6.5% and an estimated listing price near ₹130. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Bio Medica Laboratories Ltd. IPO is open for subscription from 21 May 2026 to 25 May 2026. It is expected to list on 29 May 2026.
The Bio Medica Laboratories Ltd. IPO is priced at ₹139 per share, with a total issue size of ₹52.43 Cr.
As of 21 Jul 2026, the Bio Medica Laboratories Ltd. IPO is subscribed 2.26x.